Perimeter Solutions (PRM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
18 Dec, 2025Executive summary
Achieved FY 2024 revenue of $561.0M and Adjusted EBITDA of $280.3M, with a margin of ~50%, driven by strong Fire Safety and Specialty Products growth and operational improvements.
Adjusted EBITDA nearly tripled over three years, reflecting a 26% CAGR and margin expansion of 1,100 basis points.
Maintains market leadership in fire retardants, suppressants, and specialty products, focusing on high-barrier, mission-critical markets.
Responded effectively to major wildfires in Southern California, demonstrating operational preparedness.
Capital allocation targets private-equity-like returns (15%+) with public market liquidity.
Financial highlights
FY 2024 consolidated revenue rose 74% to $561M; Adjusted EBITDA up 190% to $280.3M; Adjusted EBITDA margin reached 50%.
Q4 2024 revenue increased 45% to $86.2M; Q4 Adjusted EBITDA up 193% to $32.9M.
Q4 GAAP EPS was $0.90; Adjusted EPS was $0.13. Full-year GAAP loss per share was $0.04; Adjusted EPS was $1.11.
Generated $172.9M in free cash flow and $188.4M in operating cash flow for 2024.
Year-end cash and cash equivalents were $198.5M, with an undrawn $100M revolver.
Outlook and guidance
CapEx assumption raised to $15–$20M annually, mainly for Fire Safety; expect 10% annual working capital increase tied to revenue growth.
Anticipate cash taxes to be 20–25% of Adjusted EBITDA after D&A and interest expense, benefiting from improved tax profile post-redomiciliation.
Expects mid- to high-single digit volume growth in Fire Retardants and expansion of fluorine-free installed base.
Normalized U.S. wildfire season framework projects 6-7M acres burned ex-Alaska, supporting stable demand.
M&A remains a high priority for capital deployment, with active search for targets.
Latest events from Perimeter Solutions
- 2025 revenue up 16%, adjusted EBITDA rose 18%, with MMT acquisition and higher leverage.PRM
Q4 202526 Feb 2026 - Q2 2024 sales up 67%, Adjusted EBITDA up 209%, but net income down 58% on higher advisory fees.PRM
Q2 20242 Feb 2026 - Market leadership, value-driven growth, and high barriers fuel sustained financial outperformance.PRM
UBS Global Materials Conference22 Jan 2026 - Q3 2024 sales and EBITDA more than doubled, but non-recurring charges led to a net loss.PRM
Q3 202414 Jan 2026 - $685M acquisition targets recurring revenue growth and market expansion in medical device manufacturing.PRM
M&A Announcement12 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor change, and strong 2024 results.PRM
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify KPMG as auditor.PRM
Proxy Filing2 Dec 2025 - Q2 2025 sales and EBITDA surged, but founder advisory fees drove a GAAP net loss.PRM
Q2 202523 Nov 2025 - Q1 net income surged to $56.7M on 22% sales growth and strong Fire Safety performance.PRM
Q1 202520 Nov 2025